Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
Clinical trial NCT03753243 · RECRUITING
Trial details
- NCT number
- NCT03753243
- Sponsor
- Mark Garzotto, MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-03
- Primary completion
- 2022-09-03
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.